Brief: Cyclo Says On Track To File IND For Phase 2 Study Of Alzheimer's Disease In H2
17/05/2021 14:49
May 17 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FIRST
QUARTER 2021 FINANCIAL RESULTS
* CYCLO THERAPEUTICS INC - ON TRACK TO FILE ITS IND FOR A
PHASE 2
STUDY OF ALZHEIMER'S DISEASE IN SECOND HALF OF 2021
Source text for Eikon: ID:nBw36w8J7a
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug